logo

RCEL

AVITA Medical·NASDAQ
--
--(--)
--
--(--)

RCEL fundamentals

AVITA Medical (RCEL) expects to report earnings on Feb 12, 2026, with estimated revenue of 17.84M (YoY -2.06%), and EPS at -0.3644 (YoY +17.18%).
Revenue estimate / YoY
17.84M
-2.06%
EPS estimate / YoY
-0.3644
+17.18%
Report date
Feb 12, 2026
Earnings Call
4:30 PM on Feb 12, 2026
Meeting link.
EPS
Revenue

Revenue & Expenses

RCEL has released its 2025 Q3 earnings report, with revenue of 17.06M, reflecting a YoY change of -12.71%, and net profit of -13.19M, showing a YoY change of 18.62%. The Sankey diagram below clearly presents RCEL's revenue sources and cost distribution.

Key Indicators

AVITA Medical (RCEL) key financial stats and ratios, covering profitability, financial health, and leverage.
AVITA Medical (RCEL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
AVITA Medical (RCEL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
AVITA Medical (RCEL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does AVITA Medical (RCEL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track AVITA Medical (RCEL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield